TipRanks
Linike Medical Group (LNMG)
OTHER OTC:LNMG
US Market
LNMG
Linike Medical Group
RESEARCH TOOLSreports

Linike Medical Group (LNMG) Ratios

17 Followers

Linike Medical Group Ratios

LNMG's free cash flow for Q3 2026 was $1.00. For the 2026 fiscal year, LNMG's free cash flow was decreased by $ and operating cash flow was $0.09. See a summary of the company’s cash flow.
Ratios
TTM
Oct 25Oct 24Oct 23Oct 22
Liquidity Ratios
Current Ratio
 5.25 3.99 3.04 3.41 0.02
Quick Ratio
 3.39 2.74 2.11 2.61 0.02
Cash Ratio
 0.02 0.06 0.08 0.10 0.02
Solvency Ratio
 0.08 0.16 >-0.01 0.05 2.12
Operating Cash Flow Ratio
 -0.08 >-0.01 -0.09 -0.29 -0.25
Short-Term Operating Cash Flow Coverage
 -0.10 >-0.01 -0.12 -0.42 -0.30
Net Current Asset Value
$ 12.87M$ 11.57M$ 6.14M$ 7.12M$ -75.27K
Leverage Ratios
Debt-to-Assets Ratio
 0.28 0.30 0.33 0.31 44.80
Debt-to-Equity Ratio
 0.41 0.46 0.52 0.49 -0.84
Debt-to-Capital Ratio
 0.29 0.31 0.34 0.33 -5.29
Long-Term Debt-to-Capital Ratio
 0.23 0.24 0.25 0.25 0.00
Financial Leverage Ratio
 1.45 1.52 1.59 1.56 -0.02
Debt Service Coverage Ratio
 0.31 0.58 -0.03 0.20 -1.04
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
 2.81 1.17 0.05 <0.01 <0.01
Interest Debt Per Share
 0.02 0.03 0.03 0.03 <0.01
Net Debt to EBITDA
 11.80 5.25 -92.20 15.43 -0.94
Profitability Margins
Gross Profit Margin
56.66%98.76%99.58%99.27%0.00%
EBIT Margin
12.24%28.91%-1.88%11.07%0.00%
EBITDA Margin
14.21%30.15%-1.45%11.80%0.00%
Operating Profit Margin
12.24%28.91%-1.88%11.07%0.00%
Pretax Profit Margin
12.24%28.91%-1.88%11.07%0.00%
Net Profit Margin
12.24%28.91%-1.88%11.07%0.00%
Continuous Operations Profit Margin
12.24%28.91%-1.88%11.07%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
100.00%100.00%100.00%100.00%100.00%
Return on Assets (ROA)
2.06%5.35%-0.44%1.81%-4669.43%
Return on Equity (ROE)
3.02%8.13%-0.70%2.82%87.66%
Return on Capital Employed (ROCE)
2.30%6.19%-0.52%2.11%87.66%
Return on Invested Capital (ROIC)
2.12%5.57%-0.46%1.90%551.44%
Return on Tangible Assets
2.06%5.35%-0.44%1.81%-4669.43%
Earnings Yield
20.39%20.78%-0.07%0.03%>-0.01%
Efficiency Ratios
Receivables Turnover
 0.95 0.90 1.38 0.77 0.00
Payables Turnover
 0.13 0.06 0.02 0.03 0.00
Inventory Turnover
 0.02 0.01 <0.01 0.01 0.00
Fixed Asset Turnover
 0.37 0.40 0.45 0.32 0.00
Asset Turnover
 0.17 0.19 0.23 0.16 0.00
Working Capital Turnover Ratio
 0.38 0.51 0.71 0.95 0.00
Cash Conversion Cycle
 18.52K 21.05K 37.78K 21.50K 0.00
Days of Sales Outstanding
 385.65 407.36 264.12 471.71 0.00
Days of Inventory Outstanding
 20.86K 26.95K 54.50K 34.92K 0.00
Days of Payables Outstanding
 2.73K 6.30K 16.99K 13.89K 0.00
Operating Cycle
 21.25K 27.35K 54.77K 35.39K 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.42 17.16 1.30 1.03 1.00
Dividend Paid and CapEx Coverage Ratio
 -2.38 -0.06 -3.36 -38.39 0.00
Capital Expenditure Coverage Ratio
 -2.38 -0.06 -3.36 -38.39 0.00
Operating Cash Flow Coverage Ratio
 -0.03 >-0.01 -0.04 -0.13 -0.30
Operating Cash Flow to Sales Ratio
 -0.05 >-0.01 -0.06 -0.25 0.00
Free Cash Flow Yield
-11.33%-1.77%-0.29%-0.07%>-0.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.07 4.83 -1.38K 3.19K -45.55K
Price-to-Sales (P/S) Ratio
 0.60 1.39 25.89 353.37 0.00
Price-to-Book (P/B) Ratio
 0.15 0.39 9.68 90.03 -39.93K
Price-to-Free Cash Flow (P/FCF) Ratio
 -8.82 -56.53 -339.64 -1.37K -156.98K
Price-to-Operating Cash Flow Ratio
 -12.53 -969.93 -440.70 -1.40K -156.98K
Price-to-Earnings Growth (PEG) Ratio
 -0.09 >-0.01 10.89 -2.00 0.00
Price-to-Fair Value
 0.15 0.39 9.68 90.03 -39.93K
Enterprise Value Multiple
 16.02 9.87 -1.87K 3.01K -45.55K
Enterprise Value
 21.58M 31.76M 355.31M 3.18B 3.01B
EV to EBITDA
 16.02 9.87 -1.87K 3.01K -45.55K
EV to Sales
 2.28 2.97 27.23 355.19 0.00
EV to Free Cash Flow
 -33.49 -120.89 -357.23 -1.37K -156.98K
EV to Operating Cash Flow
 -47.54 -2.07K -463.53 -1.41K -156.98K
Tangible Book Value Per Share
 0.06 0.06 0.05 0.05 >-0.01
Shareholders’ Equity Per Share
 0.06 0.06 0.05 0.05 >-0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.01 0.02 0.02 0.01 0.00
Net Income Per Share
 <0.01 <0.01 >-0.01 <0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.00 1.00 1.00 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.86 0.70 1.01 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.59 >-0.01 3.13 -2.28 0.29
Currency in USD